The Current State of COVID-19: How Dangerous is Delta and Other Key Questions
At this point, we’ve lived through many phases of the pandemic: closing schools and sanitizing surfaces. Mask mandates and mRNA vaccines. Now, we’ve reached a new phase, with still more questions: How dangerous is the Delta variant?
Beyond Insulin: Beyond BRI's Quest to Stop Type 1 Diabetes
The discovery of insulin 100 years ago transformed type 1 diabetes (T1D) from a death sentence to a chronic illness. Yet T1D is still a relentless disease with no cure.
Understanding COVID-19 Vaccine Response: New Studies for Autoimmune Disease and Down Syndrome
Throughout the pandemic, Cate Speake, PhD, and the Center for Interventional Immunology have conducted countless COVID-19 studies — from understanding how the immune system responds to the virus to testing the Pfizer vaccine.
The Boeing Classic is Back!
The Boeing Classic is back! After the event was canceled in 2020 due to the pandemic, we can’t wait to host the annual golf tournament and fundraiser from August 16-22, 2021.
Hiking and Backpacking with Type 1 Diabetes: Tips and Stories from A Washington Hiker
After six miles and several hours of hiking in the heat of the day, Andrea Williams reached her destination: A view of Mount Rainier so close and clear that she couldn’t even fit the whole mountain in a photo. Then she checked her blood sugar.
Using Data to Fight Asthma
Picture this: A kid joins an asthma study and donates a blood sample through a new research network called Childhood Asthma in Urban Settings (CAUSE). That sample could travel as far as 3,000 miles to get to BRI.
Immunowhat? Making Sense of What It Means to be Immunocompromised
Words like “immunocompromised” are broad by design: They’re meant to encompass how a wide variety of conditions impact the immune system.
New Drug Aims to Retrain the Immune System in T1D
What if doctors could treat type 1 diabetes (T1D) by teaching the immune system to stop attacking cells in the pancreas? BRI researchers are working with the pharmaceutical company Novo Nordisk and global research consortium T1D TrialNet, testing a new approach that aims to do just that.
Hope for MS Powers Support for BRI
Debra Smith first learned about BRI when a friend invited her to the Boeing Classic Golf Tournament in the early 2010s. BRI’s work became personal when she was diagnosed with multiple sclerosis (MS) in 2013.
Understanding EOE: New Studies Shed Light on Complex Condition
Eosinophilic esophagitis (EOE), a rare immune system condition that’s connected to food allergies and causes serious inflammation in the esophagus. A BRI research team, led by Karen Cerosaletti, PhD, and Steven Ziegler, PhD, launched a study asking some key questions about EOE.